Literature DB >> 6892892

Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.

R J Schneider, T M Woodcock, A Yagoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6892892

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

2.  A phase II clinical study of mAMSA in small cell carcinoma of the lung.

Authors:  P J Dady; A P Sappino; A Rudd; I E Smith
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.

Authors:  C West; I J Stratford; N Barrass; E Smith
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.